Journal of cataract and refractive surgery · 2016
Cataract surgery and nonsteroidal antiinflammatory drugs.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hoffman Richard S, Braga-Mele Rosa, Donaldson Kendall, Emerick Geoffrey, Henderson Bonnie, Kahook Malik, Mamalis Nick, Miller Kevin M, Realini Tony, Shorstein Neal H, Stiverson Richard K, Wirostko Barbara, ASCRS Cataract Clinical Committee and the American Glaucoma Society
Аннотация
UNLABELLED: Nonsteroidal antiinflammatory drugs (NSAIDs) have become an important adjunctive tool for surgeons performing routine and complicated cataract surgery. These medications have been found to reduce pain, prevent intraoperative miosis, modulate postoperative inflammation, and reduce the incidence of cystoid macular edema (CME). Whether used alone, synergistically with steroids, or for specific high-risk eyes prone to the development of CME, the effectiveness of these medications is compelling. This review describes the potential preoperative, intraoperative, and postoperative uses of NSAIDs, including the potency, indications and treatment paradigms and adverse effects and contraindications. A thorough understanding of these issues will help surgeons maximize the therapeutic benefits of these agents and improve surgical outcomes.
FINANCIAL DISCLOSURE: Proprietary or commercial disclosures are listed after the references.
FINANCIAL DISCLOSURE: Proprietary or commercial disclosures are listed after the references.